|Description||Recombinant protein from the full-length sequence of homo sapiens KRAS proto-oncogene, GTPase (KRAS), G12V mutant, transcript variant b (NM_004985), with a DYKDDDDK tag.|
|RefSeq Link||NM_004985; NP_004976; UniProt#: P01116; GeneID: 3845;|
|Synonyms||C-K-RAS; c-Ki-ras2; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KI-RAS; KRAS1; KRAS2; NS; NS3; RALD;|
|Molecular Weight||24.9 kDa|
|Purity||>90% by SDS-PAGE gel and Coomassie Blue staining|
|Applications||Antigens, Western, ELISA and other in vitro binding or in vivo functional assays, and protein-protein interaction studies; For research & development use only!|
|Formulation||Purified protein formulated in a sterile solution of PBS buffer, pH7.2, without any preservatives|
|Endotoxin||>Endotoxin level is < 0.1 ng/µg of protein (<1EU/µg)|
|Background||This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008].|
Customers who come to this page are also interested in the following products:
There's no citations at this moment.
There's no FAQs at this moment.
There's no reviews at this moment.